GHRP-6, 10 mg. GHRP-6 is a hexapeptide acting on the ghrelin receptor, best known for producing the strongest appetite stimulation in its group, beginning 15 to 20 minutes after injection.
GHRP-6 10 mg by Nouveaux Ltd.
25 EUR99,00 złAdd to cartIn stock
What is in the pack
All three brands of GHRP-6 here hold the same 10 mg, so the choice between them is a choice of manufacturer and price, not of quantity. Nouveaux Ltd. supplies this product as a dual-chamber cartridge: 10 mg of freeze-dried powder in one chamber and 1 ml of solvent in the other. The chambers are joined just before first use, so no liquid has to be moved from one container to another. After activation with the included millilitre the solution stands at 10 mg per millilitre, which is 100 mcg per unit on a U-100 syringe.
The conversion of an amount into insulin syringe units is worked through in the guide on syringe units, and the rules that change once the powder is dissolved are in storage.
Nouveaux Ltd. as the manufacturer
Nouveaux Ltd. has the narrowest catalogue of the three and the largest packs: BPC-157 20 mg, CJC-1295 10 mg, sermorelin 10 mg, PEG-MGF 10 mg and follistatin 2 mg are all exclusive to this brand here. A larger pack costs less per milligram, and it also stands longer once dissolved, which is the trade-off to weigh before ordering.
What the evidence says
Like GHRP-2 it raises cortisol and prolactin dose-dependently. The published data describe hormone concentrations after single administrations, not outcomes. The full account, with the sources and the limits, is on the GHRP-6 page, and the background in the guide on the map of the differences in this class.
We publish no dosing schedules. Sold as research material, not as a medicine.
This is the Nouveaux Ltd. version of the compound known for the strongest hunger in its class. The same brand also fills the GHRP-6 and CJC-1295 combination, which is the form most often bought when the appetite effect is the point rather than the obstacle.
Concentration in this cartridge
| Total liquid | Concentration | Per unit on a U-100 syringe |
|---|---|---|
| 1 ml | 10 mg/ml | 100 mcg |
| 2 ml | 5 mg/ml | 50 mcg |
| 5 ml | 2 mg/ml | 20 mcg |
The table is arithmetic and nothing else: it converts the 10 mg in this cartridge into the concentration for a given total volume of liquid. The 1 ml row is the cartridge as supplied, after the chambers are joined; the other rows show what further dilution would give. It is not a dosing recommendation, and we publish none.
This cartridge next to the GHRP-6 vials
The same compound is sold here in two other versions: Bio-Peptide, 10 mg and Genheal, 10 mg. The molecule is identical in each; what differs is the manufacturer. All three hold the same amount, so the choice here is the manufacturer and its batch certificate, not the size.
Also from Nouveaux Ltd. in this group
Within Growth hormone peptides, Nouveaux Ltd. also supplies CJC-1295 10 mg, CJC-1295 with DAC 10 mg and GHRP-2 10 mg.
Where the hunger after GHRP-6 comes from
Ghrelin is a hormone released mainly by the stomach and known as the hunger hormone. Its level rises before a meal and falls after it. It acts through the receptor labelled GHS-R1a, present in the pituitary and in the hypothalamus. Stimulating this receptor has two effects at once: growth hormone release from the pituitary and a hunger signal from the hypothalamus.
GHRP-6 is a synthetic hexapeptide, a molecule of six amino acids, that stimulates the same receptor. It imitates ghrelin more literally than the newer compounds in this group. That is where its reputation as the peptide that makes you most hungry comes from, and where its use in mass-building phases comes from.
The appetite window: hunger after GHRP-6 starts 15 to 20 minutes after injection. If you plan to use this effect, have the meal ready beforehand rather than starting to cook when you feel it.
What about growth hormone itself
In peak growth hormone concentration per injection, GHRP-6 gives an amplitude comparable to ipamorelin or higher, while GHRP-2 is regarded as the strongest of the three. The differences in the size of the pulse are smaller than the differences in side effects, which is why the choice between these peptides is usually made on appetite and hormonal profile rather than on amplitude. GHRP-6, GHRP-2 and hexarelin raise cortisol and prolactin dose-dependently; ipamorelin is the only one of the four that does not.
The cartridge in practice
The Nouveaux Ltd. pack is a dual-chamber cartridge: 10 mg of powder in one chamber and 1 ml of solvent in the other. The chambers are joined just before first use, so nothing has to be transferred between containers. After activation the solution stands at 10 mg per millilitre, or 100 mcg per unit on a U-100 syringe. Let it dissolve on its own, without shaking, and keep the activated cartridge in the fridge at 2 to 8 degrees Celsius, away from light.
Who this cartridge is for
You are building mass, lack appetite and want nothing to prepare: this is the pack. You want a choice of concentration: pick the Bio-Peptide box with two 1 ml ampoules. You are in a fat-loss phase and want growth hormone release without the hunger: take ipamorelin.
GHRP-6 in a 2026 phase 3 trial
GHRP-6 has been studied not only for growth hormone. In Cuba it was tested as a drug to support the brain after stroke. In 2026 the Journal of Clinical Neuroscience published the phase 3 trial COURAGE-2 in 188 people after acute ischaemic stroke.
| What was measured | Result |
|---|---|
| Treatment | intravenous epidermal growth factor and GHRP-6 for 7 days, against standard treatment |
| Result in the whole group | no difference from standard treatment |
| Subgroup of 27 people with severe stroke | less disability after 6 months and a lower risk of death |
| Stroke in the middle cerebral artery territory | the stroke area shrank more |
| Serious adverse events | none were linked to the treatment |
This trial concerns hospital treatment, not research material. It matters for a different reason: it shows GHRP-6 given to seriously ill people for a week within a randomised trial, with no serious side effects linked to the treatment.
How long GHRP-6 stays in the blood
The pharmacokinetics of GHRP-6 were studied in 2013, also in Cuba, in nine healthy men. They received a single intravenous dose, and the peptide level was measured by chromatography with mass detection.
- Distribution phase: half-life of about 7.6 minutes.
- Elimination phase: half-life of about 2.5 hours.
- Dose dependence: the amount of peptide in the blood rose in proportion to the dose.
- After 12 hours: the level fell to the limit of detection.
All the human studies are gathered in the guide GHRP-2, GHRP-6 and ipamorelin.
Sources: Hernández-Bernal et al., Journal of Clinical Neuroscience 2026, Cabrales et al., European Journal of Pharmaceutical Sciences 2013.
Questions
How much GHRP-6 is in this cartridge?
10 mg of lyophilised powder from Nouveaux Ltd., in a dual-chamber cartridge with 1 ml of solvent.
What concentration does the included millilitre give?
10 mg per millilitre, which is 100 mcg per unit on a U-100 insulin syringe. Other volumes are in the table above.
Is this the same molecule as the Bio-Peptide vial?
Yes. GHRP-6 is the same compound in every pack here, and both hold 10 mg. What differs is the manufacturer and the batch certificate that comes with it.
Verification and delivery
Every pack carries a code under the hologram and comes from a batch with a certificate of analysis; how to check both is described in check your product. We ship within Poland and abroad. Outside Poland shipping costs 30 EUR paid in advance or 80 EUR cash on delivery, the same for every country: shipping and payments.